Javara and Ogden Clinic have announced the launch of a partnership to integrate industry-sponsored clinical trials at the point of care for Ogden Clinic patients. Through this partnership, Javara will enable access to clinical trials for patients throughout the Ogden Clinic network by providing services to support and conduct research. The Ogden Clinic currently spans 20 locations in northern Utah and includes 171 practitioners across 24 specialties.
Javara will embed clinical research infrastructure and site staff, led by Javara’s Clinical Trial Navigators, who will work alongside the practitioners and medical staff to scale clinical trial operations. Javara and Ogden Clinic anticipate early clinical trials in general medicine, pediatrics, and dermatology, with initial trials expected to begin in 4th quarter of 2021.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Vabysmo Shows Significant Vision Improvement for Diabetic Macular Edema in Underrepresented Patients
October 22nd 2024Phase IV ELEVATUM trial results show that one year of treatment with Vabysmo significantly improved vision in underrepresented racial and ethnic groups with diabetic macular edema, supporting the drug's efficacy and safety across diverse populations.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Clesrovimab Shows Significant Reduction in RSV Infections, Hospitalizations in Infants
October 18th 2024Merck's investigational monoclonal antibody, clesrovimab, shows significant efficacy in reducing respiratory syncytial virus-related infections and hospitalizations in infants, with a favorable safety profile.